Shares of Genocea Biosciences fell today after the company announced the pricing terms of their secondary offering. Is the move meaningful, or just market noise?
Shares of Genocea Biosciences fell today after the company announced the pricing terms of their secondary offering. Is the move meaningful, or just market noise?